FR2802533B1 - Phenoxypropanolamines, leur preparation et leur application en therapeutique - Google Patents

Phenoxypropanolamines, leur preparation et leur application en therapeutique

Info

Publication number
FR2802533B1
FR2802533B1 FR9915933A FR9915933A FR2802533B1 FR 2802533 B1 FR2802533 B1 FR 2802533B1 FR 9915933 A FR9915933 A FR 9915933A FR 9915933 A FR9915933 A FR 9915933A FR 2802533 B1 FR2802533 B1 FR 2802533B1
Authority
FR
France
Prior art keywords
group
alk
alkyl
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9915933A
Other languages
English (en)
French (fr)
Other versions
FR2802533A1 (fr
Inventor
Philippe R Bovy
Roberto Cecchi
Olivier Venier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9915933A priority Critical patent/FR2802533B1/fr
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to EP00988936A priority patent/EP1242404B1/fr
Priority to AT00988936T priority patent/ATE270668T1/de
Priority to DE60012048T priority patent/DE60012048T2/de
Priority to PCT/FR2000/003559 priority patent/WO2001044227A1/fr
Priority to JP2001544717A priority patent/JP2003528046A/ja
Priority to AU25273/01A priority patent/AU2527301A/en
Priority to US10/149,626 priority patent/US6852736B2/en
Publication of FR2802533A1 publication Critical patent/FR2802533A1/fr
Application granted granted Critical
Publication of FR2802533B1 publication Critical patent/FR2802533B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9915933A 1999-12-17 1999-12-17 Phenoxypropanolamines, leur preparation et leur application en therapeutique Expired - Fee Related FR2802533B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9915933A FR2802533B1 (fr) 1999-12-17 1999-12-17 Phenoxypropanolamines, leur preparation et leur application en therapeutique
AT00988936T ATE270668T1 (de) 1999-12-17 2000-12-15 Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
DE60012048T DE60012048T2 (de) 1999-12-17 2000-12-15 Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
PCT/FR2000/003559 WO2001044227A1 (fr) 1999-12-17 2000-12-15 Phenoxypropanolamines, leur preparation et leur application en therapeutique
EP00988936A EP1242404B1 (fr) 1999-12-17 2000-12-15 Phenoxypropanolamines, leur preparation et leur application en therapeutique
JP2001544717A JP2003528046A (ja) 1999-12-17 2000-12-15 フェノキシプロパノールアミン類、それらの製造および治療的使用
AU25273/01A AU2527301A (en) 1999-12-17 2000-12-15 Phenoxypropanolamines, preparation and therapeutic use thereof
US10/149,626 US6852736B2 (en) 1999-12-17 2000-12-15 Phenoxypropanolamines, preparation and therapeutic use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915933A FR2802533B1 (fr) 1999-12-17 1999-12-17 Phenoxypropanolamines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2802533A1 FR2802533A1 (fr) 2001-06-22
FR2802533B1 true FR2802533B1 (fr) 2002-02-15

Family

ID=9553378

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9915933A Expired - Fee Related FR2802533B1 (fr) 1999-12-17 1999-12-17 Phenoxypropanolamines, leur preparation et leur application en therapeutique

Country Status (8)

Country Link
US (1) US6852736B2 (enExample)
EP (1) EP1242404B1 (enExample)
JP (1) JP2003528046A (enExample)
AT (1) ATE270668T1 (enExample)
AU (1) AU2527301A (enExample)
DE (1) DE60012048T2 (enExample)
FR (1) FR2802533B1 (enExample)
WO (1) WO2001044227A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
US6525202B2 (en) 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US6444685B1 (en) 2000-07-17 2002-09-03 Wyeth N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
US6458817B1 (en) 2000-07-17 2002-10-01 Wyeth Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists
US6506901B2 (en) 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
US6451814B1 (en) 2000-07-17 2002-09-17 Wyeth Heterocyclic β-3 adrenergic receptor agonists
US6509358B2 (en) 2000-07-17 2003-01-21 Wyeth Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6395762B1 (en) 2000-07-17 2002-05-28 American Home Products Corporation Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
US6514991B2 (en) 2000-07-17 2003-02-04 Wyeth Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists
US6410734B1 (en) 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
US6498170B2 (en) 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0300458D0 (sv) * 2003-02-19 2003-02-19 Astrazeneca Ab Novel compounds
SE0300456D0 (sv) * 2003-02-19 2003-02-19 Astrazeneca Ab Novel compounds
SE0300457D0 (sv) * 2003-02-19 2003-02-19 Astrazeneca Ab Novel compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
CN1980929A (zh) * 2004-02-24 2007-06-13 比奥阿克松医疗技术股份有限公司 4－取代哌啶衍生物
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
EP1947103A1 (en) * 2007-01-22 2008-07-23 4Sc Ag Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments
JP2010535172A (ja) * 2007-08-02 2010-11-18 エフ．ホフマン−ラ ロシュ アーゲー Ｃｎｓ障害の処置のためのベンズアミド誘導体の使用
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CN108713019B (zh) 2016-03-17 2021-06-15 豪夫迈·罗氏有限公司 具有作为taar的激动剂的活性的5-乙基-4-甲基-吡唑-3-甲酰胺衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095454A3 (de) * 1982-05-13 1985-04-03 Gerot-Pharmazeutika Gesellschaft m.b.H. Neue kernsubstituierte Pyrogallol-Derivate
DE3524955A1 (de) * 1984-07-19 1986-01-30 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
GB2163150B (en) * 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
FR2780057B1 (fr) * 1998-06-18 2002-09-13 Sanofi Sa Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
US20030105135A1 (en) 2003-06-05
EP1242404B1 (fr) 2004-07-07
JP2003528046A (ja) 2003-09-24
ATE270668T1 (de) 2004-07-15
EP1242404A1 (fr) 2002-09-25
DE60012048T2 (de) 2005-07-28
FR2802533A1 (fr) 2001-06-22
AU2527301A (en) 2001-06-25
DE60012048D1 (de) 2004-08-12
US6852736B2 (en) 2005-02-08
WO2001044227A1 (fr) 2001-06-21

Similar Documents

Publication Publication Date Title
FR2802533B1 (fr) Phenoxypropanolamines, leur preparation et leur application en therapeutique
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
DE69523169D1 (de) Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
DE69637097D1 (de) 8-azabicyclo(3.2.1)oct-2en-derivate, deren herstellung und anwendung
DK0628311T3 (da) Xanthinderivater som antidepressive midler
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
PE69299A1 (es) Compuestos calciliticos
DE69313051D1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
BG100883A (en) Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors
MY116280A (en) A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist
KR920006322A (ko) 벤젠, 피리딘 및 피리미딘 유도체
PL339368A1 (en) Composition of monoamine oxidase inhibitor and antagonist or partial agonist of h5-ht 1b
FR2508033B1 (enExample)
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
DE602004007181D1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
HUP0103347A2 (hu) Béta3 adrenerg agonista hatású amino-alkohol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AR048948A1 (es) Una composicion farmaceutica antimicobacteriana
SE9902387D0 (sv) New pharmaceutically active compounds
EP1567508A4 (en) 1,2,4-TRIAZOLE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
IL114753A0 (en) New use and new derivatives of imidazole their preparation the new intermediates obtained their use as medicaments and the pharmaceutical compositions containing them
ES2102190T3 (es) Metilbutoxi-propionitrilos y su uso como perfumes.
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
PT850225E (pt) Intermediario para preparar um composto farmaceuticamente activo
CO4761062A1 (es) Procedimientos para inhibir tumores de colon

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20120831